What are the key take aways from #BTOG24 ?

Here Drs Gerry Hanna & Fiona McDonald share updates in radiotherapy including the findings of the latest The Royal College of Radiologists audit data on quality & numbers. Also RT in oncogene-addicted #lungcancer vs non-addicted.

Stay tuned for more. #LCSM

Our work on macrophage immunotherapy - Kipp Weiskopf, MD, PhD
Whitehead Institute

#Cancer #Immunotherapy #LungCancer #Macrophage #Immunotherapy #OncoDaily #Oncology

oncodaily.com/52939.html

Radon and Lung Cancer: Understanding the Risks Beyond Smoking - Sendurai Mani

oncodaily.com/53503.html

#oncodaily #oncology #cancer #LungCancer #RadonRisk #EnvironmentalHealth #RadonGas #CancerPrevention #PublicHealthAwareness #HomeTesting

New Treatment Approved for Early-Stage ALK+ #LungCancer .

#Alectinib is now approved to treat patients after surgical removal of ALK-positive non-small cell lung cancer (NSCLC). Learn more by visiting the ALK+ Lung Cancer Patient Gateway: bit.ly/3UvK6zW #lcsm

Team East of England coming together for our own MDT at #BTOG24 #lungcancer #TeamworkMakesTheDreamWork Cambridge University Hospitals NHS Royal Papworth Hospital NHS FT 💙 Royal Papworth Hospital Research Dept. Hinchingbrooke

This amazing new technology is changing the landscape of lung health. WATCH >> investigatetv.com/2024/04/18/new…
#Innovation #LungCancer #CancerScreening #MedTech

#TexasLung24 Vincent Lam Sidney Kimmel Cancer Center – Jefferson Health gives the best talk on Best Practices in #ALK + #lungcancer
➡️lorlatinib currently the most potent TKI ( but requires toxicity mgmt)
⬆️CNS activity ⬆️survival
➡️other treatment options- vaccines, local vs chemo consolidation

#lcsm

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
U.S. FDA Ben Solomon Fabrice Barlesi Mass General Cancer Center ASCO

#Cancer #Alectinib #ALINATrial #NSCLC #ClinicalTrial #LungCancer #OncoDaily #Oncology

oncodaily.com/52102.html

Some advances for our BRAF V600E NSCLC patients…Review to read at npj Journals - d.planchard

#Cancer #LungCancer #NSCLC #OncoDaily #Oncology #Cancer Research #Cancer Treatment

oncodaily.com/51702.html

In company of Dr Yi-Long Wu, Dr Thanyanan Baisamut (Reungwetwattana) & Dr Tony Mok. A much needed asian perspective on thoracic oncology. #NSCLC #LungCancer #Esmo #IASLC #AdvancedCourse #HongKong

Great news for our patients ! ALK Positive ALK+ International FLASCO OLACANCER #lungcancer #LCSM

A timely discussion with Narjust Florez, MD, FASCO about the ALINA trial - Ben Solomon
@iaslc

#NSCLC #LungCancer #OncoDaily #Oncology #ClinicalTrials

oncodaily.com/54341.html

Very good IO discussion during second day of TLC Conference Edgardo S. Santos, M.D., FACP, FASCO Balazs Halmos Dr. Estela Rodriguez Stephen V Liu, MD Julia Rotow MD #lungcancer #lcsm

Researchers from the Whitehead Institute and Mass General Cancer Center have developed a novel screening platform to identify drugs that render #LungCancer cells more vulnerable to macrophage attack.

Read more in Journal of Clinical Investigation: bit.ly/4aKp6LE

Inspiring blog by Dr Kate Meerkerk about co-designing a lung cancer screening service with Māori communities - Union for International #CancerControl

#Cancer #LungCancer #NewZealand #OncoDaily #Oncology #UICC

oncodaily.com/50938.html

Always warms my heart to have the opportunity to be part of La Colaborativa Health Fair with MassGeneral News Mass General Brigham. The goal is to increase access to #LCSM among our community in City of Chelsea & improve #lungcancer outcomes through early detection.

Nurse-led model of care for #cancer screening results in 58.7% screening for #lungcancer . An innovative model of care! ⁦Emily Jansen⁩ A model worth considering in 🇦🇺? ⁦A/Prof Nicole Rankin⁩ ⁦Cancer Australia⁩ catalyst.nejm.org/doi/full/10.10…

Great place to collaborate and learn from each other ⁦BTOG⁩ 2024 ⁦UHNM NHS Trust 🏥⁩ Meeting great professionals and the Steering Committee Chair of BTOG ⁦Sanjay Popat⁩ amazing✨ #patient advocate #lungcancer #peersupport #improvingtogether #BTOG2024 #lungresearch

Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC! $RHHBY #pharma #lungcancer
bit.ly/3xTIqXZ

Help us learn more about #lungcancer and #cancerprevention by joining a clinical trial today bit.ly/metformin_lung